カリフォルニア州における卵巣上皮性癌の臨床試験
カリフォルニア州内の拠点で、卵巣上皮性癌に関する10件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- UCLA - University of California Los Angeles Medical Center /ID# 274566, Los Angeles
- Scripps Md Anderson - Prebys Cancer Center /ID# 276891, San Diego
- California Pacific Medical Center - Van Ness Campus /ID# 275329, San Francisco
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT06890338ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of California, San Diego, La Jolla
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Redwood City, Redwood City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, La Jolla
被験者募集中第3相
18歳以上 · 女性 · 2026/07/21更新 · NCT07218809Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Disney Family Cancer Center, Burbank
- Scripps Clinic, La Jolla
- Palo Alto Medical Foundation, Palo Alto
被験者募集中第3相
18歳以上 · 女性 · 2026/07/02更新 · NCT06819007Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Beckman Research Institute of City of Hope, Duarte
- VA Medical Center, Fresno, Fresno
- Santa Clara Valley Medical Center, Fruitdale
- 他5件
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- City of Hope National Medical Center, Duarte
- Providence St. Jude Medical Center, Fullerton
- UCLA - JCCC Clinical Research Unit, Los Angeles
- 他2件
被験者募集中第2相
18歳以上 · 女性 · 2025/12/23更新 · NCT06690775A Study of NX-1607 in Adults With Advanced Malignancies
- University of Southern California, Los Angeles
- University of California, San Francisco, San Francisco
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/09更新 · NCT05107674Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Moores Cancer Center UC San Diego Health, La Jolla
- Keck School of Medicine of USC, Los Angeles
- UCLA, Los Angeles
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2025/08/15更新 · NCT04429542A Beta-only IL-2 ImmunoTherapY Study
- Sharp Memorial Hospital, San Diego
- Providence Saint John's Health Center, Santa Monica
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/07/09更新 · NCT05086692Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- UC San Diego Moores Cancer Center, La Jolla
- Stanford University, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2024/02/08更新 · NCT04282044ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。